Filter Results:
(2,341)
Show Results For
- All HBS Web
(2,341)
- People (5)
- News (685)
- Research (1,126)
- Events (3)
- Multimedia (22)
- Faculty Publications (544)
Show Results For
- All HBS Web
(2,341)
- People (5)
- News (685)
- Research (1,126)
- Events (3)
- Multimedia (22)
- Faculty Publications (544)
- October 2024
- Case
Allurion: Competing in the Age of GLP-1
By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso
Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details
- December 2010
- Case
Oral Rehydration Therapy
By: Nava Ashraf and Claire Qureshi
This case highlights the puzzlingly high rate of diarrhea-related child mortality in developing countries despite the existence of a simple, effective treatment: oral rehydration therapy (ORT). ORT treated extreme dehydration caused by diarrhea, which was a leading... View Details
Keywords: Health Care and Treatment; Innovation Strategy; Problems and Challenges; Developing Countries and Economies; Technological Innovation; Distribution Channels; Emerging Markets; Consumer Behavior; Performance Consistency; Performance Evaluation; Health Industry; Africa; Asia
Ashraf, Nava, and Claire Qureshi. "Oral Rehydration Therapy." Harvard Business School Case 911-035, December 2010. (Request a courtesy copy.)
- 08 Jan 2015
- News
Healthcare strategy 2015 — Back to the basics: 12 key thoughts
- January 2018
- Case
Spark Therapeutics: Pioneering Gene Therapy
By: Robert F. Higgins and Tina Liu
Spark Therapeutics is a pioneering gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed. The company is considering an initial public... View Details
Keywords: Health Care and Treatment; Innovation and Invention; Business Startups; Opportunities; Problems and Challenges; Strategy
Higgins, Robert F., and Tina Liu. "Spark Therapeutics: Pioneering Gene Therapy." Harvard Business School Case 818-059, January 2018.
- 01 Sep 2023
- News
Elevator Pitch: Standard of Care
16.9 million patients in low- and middle-income countries die due to lack of safe access to surgery; in addition, approximately 85,000 medical staff die after exposure to patient-borne pathogens. SurgiBox aims to make surgery safer for both patients and View Details
- 03 Oct 2022
- Research & Ideas
Why a Failed Startup Might Be Good for Your Career After All
the VC firm risk supporting an entrepreneur with a questionable track record? A recent paper might contain the answer. Entrepreneurs coming off an initial VC-backed failure often see their careers accelerate in their follow-on job, as... View Details
Keywords: by Sean Silverthorne
- 02 Apr 2013
- First Look
First Look: April 2
Publications 2006 Nature Reviews Beyond Magic Bullets: True Innovation in Health Care By: Narayan, Vaibhav A., Marco Mohwinckel, Gary Pisano, Michael Yang, and Husseini Manji Abstract—The molecular medicine revolution-based on advances... View Details
Keywords: Sean Silverthorne
- August 2024
- Case
Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda, Olivia Reszczynski and William Marks
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still... View Details
- Web
Measure Outcomes & Cost for Every Patient - Institute For Strategy And Competitiveness
and other front line providers. Use of these measures in a payment system will also accelerate their implementation. Read More in Publications on Outcomes Measurement Read More About ICHOM Cost Measurement Accurate cost measurement is... View Details
- Web
Publications - Institute For Strategy And Competitiveness
England Journal of Medicine Catalyst The Agenda for the Next Generation of Health Care Information Technology by Thomas W. Feeley, Zachary Landman and Michael E. Porter As the diffusion of value-based health... View Details
- 06 Aug 2020
- News
Companies Must Go Beyond Random Acts of Humanitarianism
- Web
About - Business & Environment
development to practice, integrate climate in the core of the management curriculum, and drive new course development on a range of topics from climate finance to adaptation and resilience, to accelerating climate solutions. She leads an... View Details
- Program
Compensation Committees
professional network Extend your network by living and working with accomplished executives from various backgrounds, industries, and countries across the globe Build relationships with a diverse group of peers who can provide wide-ranging insights into your business... View Details
- 02 Sep 2015
- What Do You Think?
What's Wrong With Amazon’s Low-Retention HR Strategy?
the opportunity to earn high compensation--but jobs that often become too demanding for some employees, particularly those with health problems or family obligations. Former employees complained about bosses who lacked empathy for... View Details
- 2025
- Working Paper
Antibiotic Treatments for Ulcers--Eradicating H-Pylori Infections: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how a chance discovery of bacteria that infect stomach linings completely changed how physicians treat ulcers. Specifically, we chronicle how: 1) two Australian physicians brought the bacterial infection to the world’s attention and... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Antibiotic Treatments for Ulcers--Eradicating H-Pylori Infections: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-006, July 2019. (Revised January 2025.)
- 22 Apr 2009
- Working Paper Summaries
Where is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
- Web
Student Journey - Entrepreneurship
RVP, you’ll select and determine funding for the Rock Accelerator program team. You’ll also intern at a VC firm during your EC year and meet with VCs at some of the top firms in the country. And check out the Venture Capital & Private... View Details
- 07 Feb 2022
- Research & Ideas
Digital Transformation: A New Roadmap for Success
challenges these leaders confronted and strategies for how to address them. Organizational change is never easy, but our roundtable discussions made clear that achieving digital maturity can be an especially arduous journey, even for... View Details
- 20 Apr 2011
- Research & Ideas
Blind Spots: We’re Not as Ethical as We Think
candidates. Such actions are not without consequences. The Challenger space shuttle explosion, steroid use in major league baseball, and the financial crash are all results of unethical decision-making, even though the participants at the... View Details
Keywords: by Sean Silverthorne